Related Experiment Video
Updated: Jan 19, 2026

A Fluorescence-based Assay of Phospholipid Scramblase Activity
Published on: September 20, 2016
Tafazzin modulates cellular phospholipid composition to regulate AML stemness
Ayesh K Seneviratne1,2, Mingjing Xu1, Aaron D Schimmer1,2,3
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Abstract:
Tafazzin is a mitochondrial enzyme necessary for the remodeling of the phospholipid cardiolipin. Seneviratne and Xu et al. demonstrated that Tafazzin-mediated phospholipid production regulates stemness in Acute Myeloid Leukemia (AML). Tafazzin influenced intracellular levels of phospholipids to control AML stemness. Thus, inhibiting mitochondrial phospholipid production could be a new therapeutic strategy for AML.
Related Concept Videos
09:52A Fluorescence-based Assay of Phospholipid Scramblase Activity
09:44High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
05:49Electrically Conductive Scaffold to Modulate and Deliver Stem Cells
02:43Quantitative Flow Cytometry to Study Labeled Protein-Phospholipid Vesicle Interactions
Regulation of Hematopoietic Stem Cells
Master Transcription Regulators

